Detection of myxoid liposarcoma-associated FUS–DDIT3 rearrangement variants including a newly identified breakpoint using an optimized RT-PCR assay

[1]  F. Grosso,et al.  Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors , 2009, Molecular Cancer Therapeutics.

[2]  C. Antonescu,et al.  Diagnosis and management of lipomatous tumors , 2008, Journal of surgical oncology.

[3]  A. Lazar,et al.  Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays. , 2008, Human pathology.

[4]  H. Moch,et al.  Relevance of translocation type in myxoid liposarcoma and identification of a novel EWSR1‐DDIT3 fusion , 2007, Genes, chromosomes & cancer.

[5]  Robin L. Jones,et al.  Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study. , 2007, The Lancet. Oncology.

[6]  M. Mehren.  Trabectedin—a targeted chemotherapy? , 2007 .

[7]  Nicolò Riggi,et al.  Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma. , 2006, Cancer research.

[8]  P. Åman,et al.  The myxoid/round cell liposarcoma fusion oncogene FUS-DDIT3 and the normal DDIT3 induce a liposarcoma phenotype in transfected human fibrosarcoma cells. , 2006, The American journal of pathology.

[9]  Owen J. Marshall.  PerlPrimer: cross-platform, graphical primer design for standard, bisulphite and real-time PCR , 2004, Bioinform..

[10]  C. Antonescu,et al.  Molecular Variability of TLS - CHOP Structure Shows No Significant Impact on the Level of Adipogenesis: A Comparative Ultrastructural and RT-PCR Analysis of 14 Cases of Myxoid/Round Cell Liposarcomas , 2003, Ultrastructural pathology.

[11]  E. Conrad,et al.  RNA splicing mediated by YB‐1 is inhibited by TLS/CHOP in human myxoid liposarcoma cells , 2002, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[12]  M. Ladanyi,et al.  Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  F. Mertens,et al.  A novel FUS/CHOP chimera in myxoid liposarcoma. , 2000, Biochemical and biophysical research communications.

[14]  G. Adelmant,et al.  Human Translocation Liposarcoma-CCAAT/Enhancer Binding Protein (C/EBP) Homologous Protein (TLS-CHOP) Oncoprotein Prevents Adipocyte Differentiation by Directly Interfering with C/EBPβ Function* , 1998, The Journal of Biological Chemistry.

[15]  M. Ushijima,et al.  Detection of TLS/FUS‐CHOP Fusion Transcripts in Myxoid and Round Cell Liposarcomas by Nested Reverse Transcription‐Polymerase Chain Reaction Using Archival Paraffin‐embedded Tissues , 1998, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[16]  J. Goldblum,et al.  Myxoid/round cell liposarcoma of the extremities. A clinicopathologic study of 29 cases with particular attention to extent of round cell liposarcoma. , 1996, The American journal of surgical pathology.

[17]  M. Höglund,et al.  Fusion of the EWS and CHOP genes in myxoid liposarcoma. , 1996, Oncogene.

[18]  S. Mori,et al.  Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma. , 1995, The American journal of pathology.

[19]  N. Mandahl,et al.  Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma , 1993, Nature.

[20]  R. Larson,et al.  Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma , 1993, Nature Genetics.

[21]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[22]  M. von Mehren.  Trabectedin--a targeted chemotherapy? , 2007, The Lancet. Oncology.

[23]  F. Mertens,et al.  World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone , 2002 .

[24]  E. Berg,et al.  World Health Organization Classification of Tumours , 2002 .

[25]  S Rozen,et al.  Primer3 on the WWW for general users and for biologist programmers. , 2000, Methods in molecular biology.